Literature DB >> 10397910

MPEO-PLA nanoparticles: effect of MPEO content on some of their surface properties.

M F Zambaux1, F Bonneaux, R Gref, E Dellacherie, C Vigneron.   

Abstract

Nanoparticles of poly(lactic acid) (PLA) and of blends of PLA and monomethoxypoly(ethylene oxyde) (MPEO-PLA) were prepared by the double emulsion method. Sucrose was added to overcome nanoparticle aggregation with freeze-drying. Whereas PLA nanoparticles rapidly are phagocytosed by the mononuclear phagocyte system cells, the uptake of MPEO-PLA nanoparticles is delayed. Opsonization is one of the steps of phagocytosis, and serum complement is a major component of the opsonin system. The in vitro complement consumption of the prepared nanoparticles was evaluated as a function of time and of their surface area. To avoid the aggregation of MPEO-PLA nanoparticles due to MPEO crystallization, sucrose was necessary, and its concentration was dependent on MPEO proportion in the nanoparticle suspension. As expected, the complement consumption for PLA nanoparticles is faster and more important than for PLA/MPEO-PLA blends. The complement consumption decreases with the increase in MPEO surface density. Complement is less consumed with the lower surface density provided by a higher molecular weight than by the higher surface density provided by a lower molecular weight MPEO. The complement consumption seems to be dependent on the number of nanoparticles in contact with human serum. Finally, the model of steric repulsion of MPEO towards proteins and the importance of the surface density of MPEO were emphasized. Copyright 1999 John Wiley & Sons, Inc.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10397910     DOI: 10.1002/(sici)1097-4636(199901)44:1<109::aid-jbm12>3.0.co;2-c

Source DB:  PubMed          Journal:  J Biomed Mater Res        ISSN: 0021-9304


  7 in total

1.  Studies of the cellular uptake of hydrogel nanospheres and microspheres by phagocytes, vascular endothelial cells, and smooth muscle cells.

Authors:  Kytai Truong Nguyen; Kajal P Shukla; Miriam Moctezuma; Arthur R C Braden; Jun Zhou; Zhibing Hu; Liping Tang
Journal:  J Biomed Mater Res A       Date:  2009-03-15       Impact factor: 4.396

2.  Harnessing the versatility of PLGA nanoparticles for targeted Cre-mediated recombination.

Authors:  Ngoc B Nguyen; Cheng-Han Chen; Yulong Zhang; Peng Zhao; Benjamin M Wu; Reza Ardehali
Journal:  Nanomedicine       Date:  2019-04-23       Impact factor: 5.307

3.  Effect of sugars, surfactant, and tangential flow filtration on the freeze-drying of poly(lactic acid) nanoparticles.

Authors:  Samuli Hirsjärvi; Leena Peltonen; Jouni Hirvonen
Journal:  AAPS PharmSciTech       Date:  2009-04-21       Impact factor: 3.246

4.  Improved anti-tumor efficiency against prostate cancer by docetaxel-loaded PEG-PCL micelles.

Authors:  Ming-Ji Jin; Sheng-Jun Piao; Tie-Xiong Jin; Zhe-Hu Jin; Xue-Zhe Yin; Zhong-Gao Gao
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2014-02-06

5.  Adjuvant-carrying synthetic vaccine particles augment the immune response to encapsulated antigen and exhibit strong local immune activation without inducing systemic cytokine release.

Authors:  Petr O Ilyinskii; Christopher J Roy; Conlin P O'Neil; Erica A Browning; Lynnelle A Pittet; David H Altreuter; Frank Alexis; Elena Tonti; Jinjun Shi; Pamela A Basto; Matteo Iannacone; Aleksandar F Radovic-Moreno; Robert S Langer; Omid C Farokhzad; Ulrich H von Andrian; Lloyd P M Johnston; Takashi Kei Kishimoto
Journal:  Vaccine       Date:  2014-03-01       Impact factor: 3.641

Review 6.  In vitro and in vivo evaluation of microparticulate drug delivery systems composed of macromolecular prodrugs.

Authors:  Hiraku Onishi; Yoshiharu Machida
Journal:  Molecules       Date:  2008-08-10       Impact factor: 4.411

7.  Development of a docetaxel micellar formulation using poly(ethylene glycol)-polylactide-poly(ethylene glycol) (PEG-PLA-PEG) with successful reconstitution for tumor targeted drug delivery.

Authors:  Taehoon Sim; Jae Eun Kim; Ngoc Ha Hoang; Jin Kook Kang; Chaemin Lim; Dong Shik Kim; Eun Seong Lee; Yu Seok Youn; Han-Gon Choi; Hyo-Kyung Han; Kwon-Yeon Weon; Kyung Taek Oh
Journal:  Drug Deliv       Date:  2018-11       Impact factor: 6.419

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.